ESC 365 - Immune checkpoints as novel mechanism in heart failure and predictors of outcomes

HFA Premium Access

Immune checkpoints as novel mechanism in heart failure and predictors of outcomes

Session: Young Investigator Award: basic science

Topic: Pathophysiology

Speaker: Doctor W. Meijers (Rotterdam, NL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Wouter Meijers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 presentations

3 followers

3 more presentations in this session

Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy

Speaker: Mr T. Eijgenraam (Groningen, NL)

DWORF diminishes clustering of phospholamban in a PLN-R14del cardiomyopathy mouse model and extends life span

Speaker: Ms N. Stege (Groningen, NL)

Electrophysiological anomalies associated with a noonan syndrome mutation in RAF1 contribute to the development of cardiac arrhythmias

Speaker: Doctor F. Haghighi (Goettingen, DE)

Access the full session

Young Investigator Award: basic science

Speakers: Doctor W. Meijers, Mr T. Eijgenraam, Ms N. Stege, Doctor F. Haghighi

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources